Fig. 4
From: The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease

Association of CSF Aβ42 with the change in CSF DHA. Baseline CSF Aβ42 was significantly associated with the change in CSF DHA after supplementation (r = 0.37, p = 0.05). The change in DHA was calculated as the difference between 18-month CSF DHA levels and the levels at baseline. The correlation was obtained using Spearman’s correlation test. Aβ42 amyloid-β42, CSF cerebrospinal fluid, DHA docosahexaenoic acid